ArticleBMC oral health2026
Evaluation of dental practitioners' knowledge and attitudes regarding drug interactions: a cross-sectional survey.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesIn dentistry, various medications are commonly used to manage conditions and maintain patient comfort. The use of multiple medications at the same time, known as polypharmacy, often occurs to manage multiple conditions. Drug interactions in dentistry present considerable risks but reveal gaps in dentists’ knowledge. Recognizing drug interaction prevalence is essential for better prescribing and patient outcomes. This investigation aims to evaluate dentists’ comprehension of pharmaceutical interactions, clarify common misconceptions, and examine the impact of years of professional experience, specialty/doctoral training, and dental specialty field, and analyze the factors influencing dental professionals’ prescribing behaviors.
methodsThis study engaged 217 dental practitioners (dental interns and post-graduate dentists) from diverse specialties in Turkey. Participants completed a 23-question survey on drug interactions, medication management, and demographic data were analyzed descriptively to outline participant responses. Chi-square and Fisher’s exact tests compared responses according to professional experience, specialty, and education.
resultsOf 217 dentists surveyed, 73.2% had 0–10 years of experience and 76% worked in public hospitals or university clinics. Nearly half (46.5%) had specialized or doctoral training. About 64.5% reported limited knowledge of drug mechanisms, and 71.9% saw their ability to manage drug interactions as inadequate. Less than a third identified clarithromycin as a CYP3A4 inhibitor, and over 60% couldn’t name key macrolide interactions. Only 29.2% recognized drugs that raise INR with warfarin, with 41.9% lacking this knowledge. Correct responses varied by specialty, with oral and maxillofacial surgeons performing best. Nearly all (94.9%) would use decision support tools, and 44.7% wanted more training on drug interactions.
conclusionsThe study highlights the importance of specialized educational initiatives and clinical decision support systems in enhancing dentists’ understanding and management of drug interactions. Addressing these knowledge gaps is crucial for improving patient safety and optimizing pharmacotherapy within dental care settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.